Cardiovascular Medicine Book

Coronary Artery Disease

Congestive Heart Failure

Electrocardiogram

Examination

Hypertension

Hypotension

Inotrope

Hyperlipidemia

Pericardial Disorders

Obstetrics Chapter related topics

//fpnotebook.com/

Sotalol

Aka: Sotalol, Betapace
  1. Indication
    1. Ventricular Arrhythmia
    2. Supraventricular Arrhythmia
      1. Atrial Fibrillation Cardioversion
        1. Time to Cardioversion: 3-6 hours
        2. Conversion Rate: 20-52%
        3. Chronic Efficacy: 50-60%
  2. Mechanism
    1. Class III Antiarrhythmic
      1. Prolongs action potential duration
      2. Increases cardiac tissue refractoriness
    2. Class II Antiarrhythmic
      1. Non-selective Beta Blocker
  3. Adverse Effects
    1. Bradycardia
    2. Hypotension
    3. Proarrhythmia (Torsades de Pointes)
      1. Associated with doses over 320 mg per day
  4. Dosing: Oral
    1. Starting Dose: 80 mg PO bid
    2. Typical dosing: 80-160 mg PO bid
    3. Maximum: 640 mg per day
Medication Costs
Sotalol HCL (on 6/18/2017 at Walmart.com)
Sotalol HCL 80mg #30 tablets for $4.00 $0.13 each
Sotalol HCL 80mg #90 tablets for $10.00 $0.11 each
sotalol (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
SOTALOL 120 MG TABLET Generic $0.14 each
SOTALOL 160 MG TABLET Generic $0.16 each
SOTALOL 80 MG TABLET Generic $0.09 each
SOTALOL AF 120 MG TABLET Generic $0.14 each
SOTALOL AF 160 MG TABLET Generic $0.16 each
SOTALOL AF 80 MG TABLET Generic $0.09 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Sotalol (C0037707)

Definition (NCI) An ethanolamine derivative with Class III antiarrhythmic and antihypertensive properties. Sotalol is a nonselective beta-adrenergic receptor and potassium channel antagonist. In the heart, this agent inhibits chronotropic and inotropic effects thereby slowing the heart rate and decreasing myocardial contractility. This agent also reduces sinus rate, slows conduction in the atria and in the atrioventricular (AV) node and increases the functional refractory period of the AV node.
Definition (MSH) An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D013015
SnomedCT 372911006, 96301002
LNC LP16279-9, MTHU003385
English Sotalol, Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, sotalol, Sotalol [Chemical/Ingredient], antiarrhythmics sotalol, sotalol (medication), SOTALOL, Sotalol (product), Sotalol (substance)
Swedish Sotalol
Czech sotalol
Finnish Sotaloli
Russian SOTALOL, СОТАЛОЛ
Japanese ソタロール
Polish Sotalol
Spanish sotalol (producto), sotalol (sustancia), sotalol, Sotalol
French Sotalol
German Sotalol
Italian Sotalolo
Portuguese Sotalol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Betapace (C0728751)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
English Betapace, betapace
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree